Specialising in understanding the multiple stakeholders who influence the success of a product in market.
Ipsos MORI Health Division is a worldwide specialisation that focuses on understanding the motivations and influences of multiple stakeholders who impact the success of products within the pharmaceutical industry.
We have expertise in understanding issues from both a stakeholder and customer perspective.
We believe that the patient is an important stakeholder in the assessment of any particular therapy area. In our view, a more holistic approach, which really uncovers the drivers of patient behaviour, is critical to exploring product uptake and usage.
Our research approach is developed from an integrated framework of thinking around a brand’s key business issues. We provide our clients with strategic direction in response to their business issues and a roadmap for tactical action planning.
We have our finger on the pulse of changes in health policy and opinion enabling us to look at the bigger picture and evaluate our research findings in the context of the wider political environment.
Hilary Worton Head of Health Email
Lucy Bennett Director Email
Emily Peasgood Director Email
Sarah Phillips writes in Pharmaceutical Market Europe that while doctors cannot be rewarded for prescribing a particular drug, there is still a lot marketers can do to promote decision makers’ engagement with a product.
Read More
Thought-Leadership Media Pack
At Ipsos Health, we differentiate ourselves on our ‘thought-leadership’ and ability to provide pharma with a more holistic understanding of the critical issues impacting on the global healthcare sector.
At Ipsos Health, we differentiate ourselves on our ‘thought-leadership’ and ability to provide pharma with a more holistic understanding of the critical issues impacting on the global healthcare sector.